New research suggests COVID-19 mRNA vaccines could help cancer patients. Those with advanced lung or skin cancer who received Pfizer or Mod...

GlaxoSmithKline Pharmaceuticals is re-entering India's oncology market with the launch of Jemperli and Zejula, precision therapies for gyna...

Roche has received clearance to import and market Atezolizumab injection (Tecentriq) for subcutaneous administration in India, potentially ...

The Delhi High Court has granted an interim injunction against Zydus Lifesciences, an Ahmedabad-based drug maker, following a patent infrin...

University of Florida scientists have engineered an experimental mRNA vaccine that stimulates the immune system to combat tumors in conjunc...

The deal, which includes $3.5 billion in unconditional payments, underpins BioNTech's ambition to continue a costly long-term focus on expe...

Nuvama has downgraded IndusInd Bank to "Reduce" citing concerns over internal derivative trades and management changes, while Antique remai...

Former US President Jimmy Carter, who was diagnosed with melanoma that spread to his brain in 2015, has survived for nine years thanks to i...

Immune cells can fight cancerous cells says research.

The Mediterranean diet will play an important role in the success of immunotherapy.

The Mumbai-based drug major said, GRC 54276 has shown tumor cell killing ability in preclinical studies as a single agent and as well in co...

WHO estimates at least 2.8 million people die each year as a result of being overweight or obese.

Immunotherapy should be given as early as possible to achieve a lasting remission of the disease.

New York, April 8 (IANS) A novel immunotherapy combination is effective and safe at controlling the progression of lung cancer, results fro...

It may be too early to forecast how Glenmark’s drugs will fare, for the next few years, the generics business will continue to be key.

The Bengaluru-based company is an independent subsidiary of Dr Reddy’s Laboratories and its United States-based partner Curis Inc.

"The pact includes an upfront payment of $2 mn and contingent pre-clinical, clinical and regulatory payments including commercials up to $1...